Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSynectics Regulatory News (SNX)

Share Price Information for Synectics (SNX)

Share Price is delayed by 15 minutes
Get Live Data
200.00    0.00 (0.00%)
Bid:
195.00
Ask:
205.00
Spread: 10.00 (5.128%)
Market Cap: £34.01m
SNX Live PriceLast checked at - London Stock Exchange

Intraday Synectics Share Chart

AGM Statement

27 Apr 2016 07:00

RNS Number : 4256W
Synectics PLC
27 April 2016
 

For immediate release 27 April 2016

 

Synectics plc

("the Company" or "the Group")

AGM Statement

Synectics (AIM: SNX), a leader in the design, integration, control and management of advanced surveillance technology and networked security systems, is holding its Annual General Meeting at 11.00am today, at which the Chairman, David Coghlan, will make the following statement.

"I am pleased to report that Synectics has had a strong start to the year in terms of major orders won. Important new contracts secured so far this financial year include:

· Multi-million pound projects to provide integrated surveillance solutions for a new casino resort in Macau, and a mega-resort in the Philippines;

 

· The provision of a surveillance system and explosion-protected camera stations for a large oil & gas project in Algeria;

 

· A system to protect the maintenance infrastructure for one of the world's top ten international passenger airlines within the ASEAN region;

 

· Provision of on-board surveillance for a new tram fleet in Germany, commencing in 2017;

 

· The design and installation of a complex integrated security and safety system for a new power station currently under construction in the UK; and

 

· A large and complex multi-site 'threat management solution' for one of the UK's biggest financial institutions.

 

"These contracts demonstrate Synectics' business model in action, covering our specialist sector activities in gaming, oil & gas, transport and infrastructure. In each of these sectors, the respective Synectics businesses are increasingly recognised as experts in their customers' specialist fields, offering customised systems based around our own Synergy 3 core command and control software platform.

"As a result of these sales successes, the Group's total order book has increased by over 28%, from £26.6 million at the end of our last financial year to £34.2 million as at 31 March 2016.

"Despite the growing order book, the timing of revenue earned on some of these contracts has been somewhat delayed, due in part to customer construction hold-ups and, consequently, results for the year are likely to be more than usually weighted towards the second half.

"Trading in the Group's oil & gas security systems sector continues to be relatively weak, but Synectics' competitive position in the current depressed market remains strong. Based on the Group's healthy order book and current pipeline of anticipated new business, the Board's expectations for results for the full year remain in line with market forecasts."

For further information, please contact:

Synectics plc

Tel: +44 (0) 1527 850 080

David Coghlan, Chairman

Paul Webb, Chief Executive

email: info@synecticsplc.com

www.synecticsplc.com

 

Stockdale Securities

Tel: +44 (0) 20 7601 6100

Tom Griffiths / Henry Willcocks

 

Media enquiries:

Buchanan

Tel: +44 (0) 20 7466 5000

Mark Court / Sophie Cowles / Jane Glover

email: synectics@buchanan.uk.com

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
AGMBLGDSRXDBGLL
Date   Source Headline
10th Feb 20217:00 amRNSLetter of Intent and Notification of Results Date
7th Jan 20217:00 amRNSSynectics’ S-Bahn project goes live
15th Dec 20207:00 amRNSTrading Update
1st Dec 20207:00 amRNSSynectics appoints Dr Kerstin Wendt
26th Nov 20207:00 amRNSDirector/PDMR Shareholding
19th Nov 20207:36 amRNSDirector/PDMR Shareholding
18th Nov 202011:53 amRNSDirector/PDMR Shareholding
17th Nov 20207:00 amRNSContract Win
2nd Oct 202011:02 amRNSDirector/PDMR dealings
29th Sep 20207:00 amRNSTrading Update
12th Aug 20207:00 amRNSDirector/PDMR Shareholding
10th Aug 20207:00 amRNSDirectors' / PDMRs' Interests in Shares
30th Jul 20202:03 pmRNSDirector/PDMR Shareholding
28th Jul 20207:00 amRNSDirector/PDMR Shareholding
28th Jul 20207:00 amRNSContract Wins for 'next generation' Irish Buses
27th Jul 20204:40 pmRNSSecond Price Monitoring Extn
27th Jul 20204:35 pmRNSPrice Monitoring Extension
27th Jul 20207:00 amRNSHolding(s) in Company
23rd Jul 20208:22 amRNSHolding(s) in Company
14th Jul 20207:00 amRNSInterim Results
25th Jun 20209:12 amRNSHolding(s) in Company
16th Jun 20207:00 amRNSMajor Contract Win and Notice of Interim Results
22nd May 20207:00 amRNSContract Wins with Long Term Customers
23rd Apr 202011:49 amRNSResult of AGM
23rd Apr 20207:00 amRNSBusiness Update
6th Apr 202012:24 pmRNSRevised Arrangements for Annual General Meeting
2nd Apr 20209:11 amRNSDirector/PDMR Shareholding
23rd Mar 20202:28 pmRNSBusiness Update: COVID-19
23rd Mar 20201:48 pmRNSAvailability of Report and Accounts and AGM
11th Mar 20204:23 pmRNSDirector/PDMR Shareholding
11th Mar 202012:11 pmRNSHolding(s) in Company
6th Mar 20201:59 pmRNSDirector/PDMR Shareholding
25th Feb 20207:00 amRNSSettlement of Legal Claim
25th Feb 20207:00 amRNSFinal Results
11th Feb 20204:12 pmRNSHolding(s) in Company
7th Feb 20202:33 pmRNSHolding(s) in Company
7th Feb 202010:43 amRNSReplacement - Holding(s) in Company
7th Feb 20207:00 amRNSNotification of Final Results
6th Feb 20204:58 pmRNSHolding(s) in Company
30th Jan 202012:17 pmRNSReplacement - Holding(s) in Company
28th Jan 20208:58 amRNSHolding(s) in Company
23rd Jan 20209:55 amRNSDirectorate Changes
13th Dec 201912:00 pmRNSDirectorate Change
21st Nov 20198:42 amRNSChange of Registered Office
5th Nov 20198:51 amRNSHolding(s) in Company
30th Oct 201911:06 amRNSSecond Price Monitoring Extn
30th Oct 201911:00 amRNSPrice Monitoring Extension
30th Oct 20197:00 amRNSTrading Update
2nd Oct 20194:12 pmRNSDirector/PDMR Shareholding
23rd Jul 20198:31 amRNSContract Win

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.